SAPECMERAN AUTOGENE
UNII 2E99S2VU5M

Substance Identification & Data

This profile provides standardized clinical and technical data for Sapecmeran Autogene, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2E99S2VU5M.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2805319-17-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2E99S2VU5M

CAS Registry Number

2805319-17-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SAPECMERAN AUTOGENE

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C156926

National Cancer Institute reference terminology for clinical and research data.

INN ID

13101

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-168

Identifier assigned by the United States Adopted Names Council.

Substance Type

nucleicAcid

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sapecmeran Autogene. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SAPECMERAN AUTOGENE

Common Names & Synonyms

RNA (VENEZUELAN EQUINE ENCEPHALITIS VIRUS-DERIVED CONSTRUCT GRT-R902 STRUCTURAL POLYPROTEIN GENE DELETION-CONTAINING PLUS TUMOR-SPECIFIC NEOANTIGEN PROTOTYPE CASSETTE-EXPRESSING)

SAPECMERAN AUTOGENE [INN]

SAPECMERAN AUTOGENE [USAN]

SAPECMERAN AUTOGENE [WHO-DD]